Trial Profile
A retrospective descriptive and comparative mono-centric study comparing efficacy of adalimumab, infliximab and etanercept in patients with spondyloarthritis (SpA)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jul 2018
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary) ; Infliximab (Primary)
- Indications Spondylarthritis
- Focus Therapeutic Use
- 14 Jul 2018 New trial record
- 16 Jun 2018 Results presented at the 19th Annual Congress of the European League Against Rheumatism